Frontiers in Immunology,
Год журнала:
2023,
Номер
14
Опубликована: Янв. 31, 2023
Bacille
Calmette-Guérin
(BCG)
is
the
only
approved
vaccine
for
tuberculosis
(TB)
prevention
worldwide.
BCG
has
an
excellent
protective
effect
on
miliary
and
tuberculous
meningitis
in
children
or
infants.
Interestingly,
a
growing
number
of
studies
have
shown
that
vaccination
can
induce
nonspecific
specific
immunity
to
fight
against
other
respiratory
disease
pathogens,
including
SARS-CoV-2.
The
continuous
emergence
variants
SARS-CoV-2
makes
efficiency
COVID-19-specific
vaccines
unprecedented
challenge.
Therefore,
it
been
hypothesized
BCG-induced
trained
might
protect
COVID-19
infection.
This
study
comprehensively
described
mechanism
immunity.
In
addition,
this
also
reviewed
research
revaccination
prevent
TB,
impact
non-tuberculous
diseases,
clinical
trials
These
data
will
provide
new
evidence
confirm
hypotheses
mentioned
above.
Journal of Infection and Public Health,
Год журнала:
2022,
Номер
16(1), С. 4 - 14
Опубликована: Ноя. 19, 2022
Newly
emerging
variants
of
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
are
continuously
posing
high
global
public
health
concerns
and
panic
resulting
in
waves
disease
2019
(COVID-19)
pandemic.
Depending
on
the
extent
genomic
variations,
mutations
adaptation,
few
gain
ability
to
spread
quickly
across
many
countries,
acquire
higher
virulency
cause
disease,
morbidity
mortality.
These
have
been
implicated
lessening
efficacy
current
COVID-19
vaccines
immunotherapies
break-through
viral
infections
vaccinated
individuals
recovered
patients.
Altogether,
these
could
hinder
protective
herd
immunity
be
achieved
through
ongoing
progressive
vaccination.
Currently,
only
variant
interest
SARS-CoV-2
is
Omicron
that
was
first
identified
South
Africa.
In
this
review,
we
present
overview
with
a
special
focus
variant,
its
lineages
hybrid
variants.
We
discuss
hypotheses
origin,
genetic
change
underlying
molecular
mechanism
behind
transmissibility
immune
escape
variant.
Major
related
including
available
immunotherapeutics
vaccines,
transmissibility,
severity,
mortality
discussed.
last
part,
challenges
strategies
counter
amid
pandemic
presented.
Annals of Medicine,
Год журнала:
2023,
Номер
55(1), С. 285 - 291
Опубликована: Янв. 3, 2023
The
exhaustive
information
about
non-communicable
diseases
associated
with
COVID-19
and
severe
acute
respiratory
syndrome
corona
virus-2
(SARS-CoV-2)
are
getting
easier
to
find
in
the
literature.
However,
there
is
a
lack
of
knowledge
regarding
tuberculosis
(TB)
chronic
obstructed
pulmonary
disease
(COPD),
numerous
infections
patients.Priority
placed
on
determining
patient's
prognosis
based
presence
or
absence
TB
COPD.
Additionally,
comparison
made
between
risk
death
likelihood
recovery
terms
time
patients
who
have
either
COPD
TB.At
DHQ
Hospital
Muzaffargarh,
Punjab,
Pakistan,
498
were
studied
retrospectively.
duration
study
started
February
2022
concluded
August
2022.
Kaplan-Meier
curves
described
time-to-death
time-to-recovery
stratified
by
status.
Wilcoxon
test
compared
survival
rates
people
two
matched
paired
groups
their
status
differences
standard
living.The
was
1.476
times
higher
than
those
without
(95%
CI:
0.949-2.295).
0.677
lower
0.436-1.054).
Similarly,
had
significantly
shorter
(p=.001)
longer
(p=.001).According
findings,
most
significant
contributor
an
increased
morbidity
mortality
COVID-19.KEY
MESSAGESSARS-Cov-19
new
challenge
for
universe
prevention
treatment
obstructive
disease,
among
other
diseases.Propensity
score
matching
control
potential
biases.Compared
hospitalized
(TB
COPD)
equivalently
rate.
Frontiers in Pharmacology,
Год журнала:
2023,
Номер
14
Опубликована: Фев. 7, 2023
Introduction:
Coronavirus
disease
2019
(COVID-19),
caused
by
SARS-CoV-2,
has
had
a
disastrous
effect
worldwide
during
the
previous
three
years
due
to
widespread
infections
with
SARS-CoV-2
and
its
emerging
variations.
More
than
674
million
confirmed
cases
over
6.7
deaths
have
been
attributed
successive
waves
of
as
29th
January
2023.
Similar
other
RNA
viruses,
is
more
susceptible
genetic
evolution
spontaneous
mutations
time,
resulting
in
continual
emergence
variants
distinct
characteristics.
Spontaneous
increase
transmissibility,
virulence,
severity
diminish
efficacy
therapeutics
vaccines,
vaccine-breakthrough
re-infection,
leading
high
mortality
morbidity
rates.
Materials
methods:
In
this
study,
we
evaluated
10,531
whole
genome
sequences
all
reported
globally
through
computational
approach
assess
spread
genome.
The
available
data
sources
NextCladeCLI
2.3.0
(https://clades.nextstrain.org/)
NextStrain
(https://nextstrain.org/)
were
searched
for
tracking
mutations,
analysed
using
PROVEAN,
Polyphen-2,
Predict
SNP
mutational
analysis
tools
validated
Machine
Learning
models.
Result:
Compared
Wuhan-Hu-1
reference
strain
NC
045512.2,
genome-wide
annotations
showed
16,954
We
determined
that
Omicron
variant
6,307
(retrieved
sequence:1947),
including
67.8%
unique
any
study.
spike
protein
harboured
876
443
deleterious
mutations.
Among
these
187
common
256
non-synonymous
contrast,
after
analysing
1,884
Delta
variant,
discovered
4,468
which
66%
unique,
not
previously
variants.
Mutations
affecting
proteins
are
mostly
found
RBD
regions
Omicron,
whereas
most
drawn
focus
on
amino
acid
ranging
from
911
924
context
epitope
prediction
(B
cell
&
T
cell)
stability
impact
protruding
transmissible.
Discussion:
pathogenesis
could
be
prevented
if
persistent
immunosuppressive
can
targeted
vaccination
or
small-molecule
inhibitor
designing.
Thus,
our
findings
will
help
researchers
monitor
track
continuously
evolving
nature
strains,
associated
variants,
their
implications
developing
effective
control
prophylaxis
strategies.
Expert Review of Vaccines,
Год журнала:
2024,
Номер
23(1), С. 510 - 522
Опубликована: Апрель 24, 2024
COVID-19
was
an
unprecedented
challenge
worldwide;
however,
disease
epidemiology
has
evolved,
and
no
longer
constitutes
a
public
health
emergency
of
international
concern.
Nonetheless,
remains
global
threat
uncertainties
remain,
including
definition
the
end
pandemic
transition
to
endemicity,
understanding
true
rates
SARS-CoV-2
infection/transmission.
Vaccines,
Год журнала:
2024,
Номер
12(8), С. 891 - 891
Опубликована: Авг. 7, 2024
The
COVID-19
pandemic
has
underscored
the
critical
importance
of
adaptable
and
resilient
public
health
systems
capable
rapid
response
to
emerging
crises.
This
paper
synthesizes
lessons
learned
from
vaccination
campaign
explores
strategies
enhance
vaccine
uptake
in
post-pandemic
era.
Key
challenges
identified
include
logistical,
economic,
sociocultural,
policy
dimensions
that
impact
efforts,
particularly
low-resource
settings.
analysis
highlights
need
for
supply
chains,
effective
communication,
community
engagement,
equitable
access
healthcare
resources.
development
deployment
mRNA
vaccines
exemplify
potential
innovative
technologies,
though
trust
acceptance
remain
crucial.
Strategies
such
as
partnerships
with
local
leaders,
tailored
messaging,
integration
digital
tools
are
essential
combating
hesitancy.
By
applying
these
insights,
future
campaigns
can
be
more
efficient,
equitable,
resilient,
ultimately
improving
outcomes
globally.
aims
inform
practice,
ensuring
evidence
based
context
specific,
thus
better
preparing
challenges.
Vaccines,
Год журнала:
2022,
Номер
10(11), С. 1929 - 1929
Опубликована: Ноя. 15, 2022
This
study
analyzed
perceptions
of
Indians
regarding
COVID-19
booster
dose
vaccines
using
natural
language
processing
techniques,
particularly,
sentiment
analysis
and
topic
modeling.
We
tweets
generated
by
Indian
citizens
for
this
study.
In
late
July
2022,
the
government
hastened
process
vaccinations.
Understanding
emotions
concerns
health
policy
being
implemented
will
assist
government,
officials,
policymakers
implement
efficiently
so
that
desired
results
can
be
achieved.
Seventy-six
thousand
nine
hundred
seventy-nine
were
used
The
revealed
out
those
76,979
tweets,
more
than
half
(n
=
40,719
(52.8%)
had
negative
sentiments,
24,242
(31.5%)
neutral
12,018
(15.6%)
positive
sentiments.
Social
media
posts
on
doses
have
focused
feelings
younger
people
do
not
need
vaccinations
are
unhealthy.
Vaccines,
Год журнала:
2023,
Номер
11(7), С. 1181 - 1181
Опубликована: Июнь 30, 2023
Although
the
chief
of
World
Health
Organization
(WHO)
has
declared
end
coronavirus
disease
2019
(COVID-19)
as
a
global
health
emergency,
is
still
threat.
To
be
able
to
manage
such
pandemics
in
future,
it
necessary
develop
proper
strategies
and
opportunities
protect
human
life.
The
data
on
SARS-CoV-2
virus
must
continuously
analyzed,
possibilities
mutation
emergence
new,
more
infectious
variants
anticipated,
well
options
using
different
preventive
therapeutic
techniques.
This
because
fast
development
severe
acute
2
syndrome
(SARS-CoV-2)
concern
have
posed
significant
problem
for
COVID-19
pandemic
control
presently
available
vaccinations.
review
summarizes
that
are
responsible
clinical
efficacy
most
commonly
used
vaccines
practice.
consequences
after
(long
COVID
or
post-COVID
conditions)
continue
subject
studies
research,
affect
social
economic
life
worldwide.